When the prognostic impact of race, secondary cytogenetic abnormalities, sex, and response to salvage treatment is considered, t(8;21) and inv(16) AMLs seem to be distinct clinical entities and should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback